Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bovine intestinal alkaline phosphatase - Alloksys Life Sciences

Next Previous
Drug Profile

Bovine intestinal alkaline phosphatase - Alloksys Life Sciences

Alternative Names: bIAP; Bovine alkaline phosphatase - Alloksys Life Sciences; bovine RESCAP® - Alloksys; bRESCAP

Latest Information Update: 31 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Alloksys Life Sciences
  • Class Anti-inflammatories; Anti-ischaemics; Hepatoprotectants; Recombinant proteins
  • Mechanism of Action Endotoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Ischaemia
  • Phase II/III Systemic inflammatory response syndrome
  • Phase II Burns; Respiratory insufficiency
  • No development reported Rheumatoid arthritis

Most Recent Events

  • 24 Aug 2023 Alloksys plans to submit a New Drug Application (NDA) and/or Marketing Authorization Application (MAA) in the US and/or Europe
  • 24 Aug 2023 Interim efficacy data from the phase II/III trial in Systemic inflammatory response syndrome released by Alloksys
  • 24 Aug 2022 Alloksys life sciences initiates enrolment in the phase II trial for Ischaemia (Prevention) in Netherlands (IV, Infusion) (EudraCT2021-006767-14)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top